Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H29N3O2S.2C4H4O4 |
Molecular Weight | 643.705 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.CC(=O)C1=CC2=C(SC3=C(C=CC=C3)N2CCCN4CCN(CCO)CC4)C=C1
InChI
InChIKey=NUKVZKPNSKJGBK-SPIKMXEPSA-N
InChI=1S/C23H29N3O2S.2C4H4O4/c1-18(28)19-7-8-23-21(17-19)26(20-5-2-3-6-22(20)29-23)10-4-9-24-11-13-25(14-12-24)15-16-27;2*5-3(6)1-2-4(7)8/h2-3,5-8,17,27H,4,9-16H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-
Molecular Formula | C4H4O4 |
Molecular Weight | 116.0722 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Molecular Formula | C23H29N3O2S |
Molecular Weight | 411.56 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.psyweb.com/drughtm/jsp/acetop.jspCurator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17606915 | https://www.ncbi.nlm.nih.gov/pubmed/6147851
Sources: http://www.psyweb.com/drughtm/jsp/acetop.jsp
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17606915 | https://www.ncbi.nlm.nih.gov/pubmed/6147851
Acetophenazine (Tindal) is an antipsychotic drug of moderate-potency. Used in the treatment of disorganized and psychotic thinking. Acetophenazine (Tindal) is also used to help treat false perceptions (e.g. hallucinations or delusions). Acetophenazine acts as an antagonist of dopaminergic D2 receptors in the brain. Acetophenazine exhibited modest androgen receptor binding and antiandrogen activity.
Originator
Sources: https://www.google.com/patents/US2985654
Curator's Comment: reference retrieved from http://www.drugfuture.com/chemdata/Acetophenazine.html
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1871 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17606915 |
0.8 µM [Ki] | ||
Target ID: CHEMBL217 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6147851 |
17.0 nM [IC50] | ||
Target ID: CHEMBL287 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6147851 |
36.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | TINDAL Approved UseAcetophenazine ( Tindal ) is an antipsychotic drug of moderate-potency. Used in the treatment of disorganized and psychotic thinking. Acetophenazine ( Tindal ) is also used to help treat false perceptions (e.g. hallucinations or delusions.) Launch Date1961 |
PubMed
Title | Date | PubMed |
---|---|---|
Influence of acetophenazine (Tindal) upon the attitude of cardiac patients. | 1962 Mar |
|
Acetophenazine for hyperactive geriatric patients. | 1962 Sep |
|
Acetophenazine in ambulatory schizophrenic adults. | 1962 Sep |
|
EFFECTS OF ACETOPHENAZINE DIMALEATE ON PARANOID SYMPTOMATOLOGY IN FEMALE GERIATRIC PATIENTS: DOUBLE-BLIND STUDY. | 1964 Sep |
|
Acetophenazine and diazepam in anxious depressions. | 1971 Mar |
|
Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. | 1984 Sep |
|
Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. | 2007 Jul 17 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.psyweb.com/drughtm/jsp/acetop.jsp
Normal dosage: 20mg to 40mg daily, in healthy young adult.
Start: 20mg daily.
Increases: 20mg as needed.
Maintenance: As low as possible in 24 hours.
Maximum: 60mg in 24 hours.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:36:35 GMT 2023
by
admin
on
Fri Dec 15 16:36:35 GMT 2023
|
Record UNII |
3P5HNU5JTC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
||
|
NCI_THESAURUS |
C740
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C65210
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
PRIMARY | |||
|
100000078827
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
PRIMARY | |||
|
C100162
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
PRIMARY | |||
|
70600
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
PRIMARY | |||
|
3P5HNU5JTC
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | |||
|
SUB00255MIG
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | |||
|
DBSALT001415
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | |||
|
DTXSID7047851
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | |||
|
5281082
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
PRIMARY | |||
|
227-202-3
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | |||
|
2402
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | |||
|
91127
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
PRIMARY | RxNorm | ||
|
5714-00-1
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | |||
|
CHEMBL1085
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | |||
|
169180
Created by
admin on Fri Dec 15 16:36:36 GMT 2023 , Edited by admin on Fri Dec 15 16:36:36 GMT 2023
|
PRIMARY | |||
|
m991
Created by
admin on Fri Dec 15 16:36:35 GMT 2023 , Edited by admin on Fri Dec 15 16:36:35 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |